Cytomegalovirus Antibody (Igg) Fetus

Lab Reagents

Cytomegalovirus Antibody Laboratories manufactures the cytomegalovirus antibody (igg) fetus reagents distributed by Genprice. The Cytomegalovirus Antibody (Igg) Fetus reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other Cytomegalovirus products are available in stock. Specificity: Cytomegalovirus Category: Antibody Group: (Igg) Fetus

(Igg) Fetus information

Mouse antibody for Cytomegalovirus

887 100 ug
EUR 431.93
Description: This is Mouse monoclonal FITC conjugated antibody against Cytomegalovirus pp65 for WB, ELISA.

Anti-Human Cytomegalovirus antibody

STJ16100451 1 mL
EUR 1092

Anti-Cytomegalovirus p65 antibody

STJ16101049 100 µg
EUR 424.8

Anti-Cytomegalovirus p65 antibody

STJ16101050 100 µg
EUR 424.8

Anti-Cytomegalovirus p65 antibody

STJ16101051 100 µg
EUR 424.8

Cytomegalovirus Antibody / CMV / PP65

V2332-100UG 100 ug
EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

V2332-20UG 20 ug
EUR 219
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

V2332SAF-100UG 100 ug
EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

V2333-100UG 100 ug
EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cytomegalovirus Antibody / CMV / PP65

V2333-20UG 20 ug
EUR 219
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cytomegalovirus Antibody / CMV / PP65

V2333SAF-100UG 100 ug
EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Fetus (11 Day Fetus) Lysate

21-390 0.1 mg
EUR 342.6
Description: Mouse fetus (11 day fetus) tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The mouse fetus (11 day fetus) tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the fetus (11 day fetus) tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The fetus (11 day fetus) tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Fetus (17 Day Fetus) Lysate

21-392 0.1 mg
EUR 342.6
Description: Mouse fetus (17 day fetus) tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The mouse fetus (17 day fetus) tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the fetus (17 day fetus) tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The fetus (17 day fetus) tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Fetus (11 Day Fetus) Lysate

21-467 0.1 mg
EUR 342.6
Description: Rat fetus (11 day fetus) tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The rat fetus (11 day fetus) tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the fetus (11 day fetus) tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The fetus (11 day fetus) tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Fetus Lysate (14 Day Fetus)

1451-F14 0.1 mg
EUR 229.2
Description: Fetus lysate (14 Day Fetus) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Fetus Lysate (7 Day Fetus)

1451-F7 0.1 mg
EUR 229.2
Description: Fetus lysate (7 Day Fetus) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Recombinant Cytomegalovirus Pp38

DAG531 1mg
EUR 1537.2